PRE-EXISTING AND ACQUIRED MORE FREQUENT KD MUTATIONS OF BCR-ABL IN PRIMARY AND SECONDARY RESISTANT IMATINIB-TREATED CML PATIENTS

被引：0
|
作者：
Vrsalovic, M. Marusic [1 ]
Duic, I. [1 ]
Ajdukovic, R. [1 ]
Haris, V. [1 ]
Pejsa, V. [1 ]
Jaksic, O. [1 ]
Kusec, R. [1 ]
机构：
[1] Dubrava Univ Hosp, Zagreb, Croatia
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1316
引用
收藏
页码：533 / 534
页数：2
相关论文
共 50 条
  • [31] Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL
    Ross, DM
    Branford, S
    Moore, S
    Hughes, TP
    LEUKEMIA, 2006, 20 (04) : 664 - 670
  • [32] BCR-ABL KINASE DOMAIN MUTATION FREQUENCY IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS RESISTANT TO IMATINIB THERAPY
    Tikhonova, V.
    Misyurina, E.
    Kesaeva, L.
    Finashutina, Y.
    Krutov, A.
    Aksenova, E.
    Soldatova, I.
    Soldatkina, O.
    Ivanova, V.
    Novitskaya, N.
    Arshanskaya, E.
    Lazarev, I.
    Volkova, M.
    Pospelova, T.
    Konstantinova, T.
    Vysotskaya, L.
    Voloditcheva, E.
    Lapin, V.
    Davydkin, I.
    Turkina, A.
    Kolosheinova, T.
    Goryacheva, S.
    Chelysheva, E.
    Pristupa, A.
    Golubenko, R.
    Gavrilova, L.
    Volkova, S.
    Kuchma, G.
    Ovsyannikova, E.
    Zaklyakova, L.
    Kaplanov, K.
    Klitochenko, T.
    Misyurin, A.
    HAEMATOLOGICA, 2013, 98 : 548 - 548
  • [33] ACQUIRED IMATINIB RESISTANCE IN CML IS ASSOCIATED WITH TKD MUTATIONS OF BCR-ABL AND/OR ADDITIONAL CHROMOSOMAL ABERRATIONS: CERTAIN TKD MUTATIONS ARE ASSOCIATED WITH CHROMOSOME INSTABILITY
    Dicker, F.
    Kern, W.
    Haferlach, T.
    Haferlach, C.
    Schnittger, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 344 - 344
  • [34] BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?
    Gruber, Franz X.
    Lundan, Tuija
    Goll, Rasmus
    Silye, Aleksandra
    Mikkola, Ingvild
    Rekvig, Ole Petter
    Knuutila, Sakari
    Remes, Kari
    Gedde-Dahl, Tobias
    Porkka, Kimmo
    Hjorth-Hansen, Henrik
    MEDICAL ONCOLOGY, 2012, 29 (01) : 219 - 226
  • [35] BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?
    Franz X. Gruber
    Tuija Lundán
    Rasmus Goll
    Aleksandra Silye
    Ingvild Mikkola
    Ole Petter Rekvig
    Sakari Knuutila
    Kari Remes
    Tobias Gedde-Dahl
    Kimmo Porkka
    Henrik Hjorth-Hansen
    Medical Oncology, 2012, 29 : 219 - 226
  • [36] Coexistence of AML1/RUNX1 and BCR-ABL point mutations in an imatinib-resistant form of CML
    S Corm
    V Biggio
    C Roche-Lestienne
    J-L Laï
    I Yakoub-Agha
    N Philippe
    F-E Nicolini
    T Facon
    C Preudhomme
    Leukemia, 2005, 19 : 1991 - 1992
  • [37] IMPACT OF BCR-ABL MUTATIONS ON RESPONSE TO DASATINIB IN ELDERLY CHRONIC MYELOID LEUKEMIA PATIENTS RESISTANT TO IMATINIB
    Tiribelli, M.
    Latagliata, R.
    Breccia, M.
    Luciano, L.
    Castagnetti, F.
    Gozzini, A.
    Cambrin, G. Rege
    Annunziata, M.
    Stagno, F.
    Pregno, P.
    Albano, F.
    Abruzzese, F.
    Musto, P.
    Sora, F.
    Ferrero, D.
    Montefusco, E.
    Cavazzini, F.
    Binotto, G.
    Fanin, R.
    Pane, F.
    Rosti, G.
    Santini, V.
    Fava, C.
    Alimena, G.
    Vigneri, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 347 - 347
  • [38] BCR-ABL kinase domain mutations & SNPs in imatinib resistant or intolerant chronic myeloid leukaemia patients
    O'Connor, Lisa M.
    Langabeer, Stephen
    McCann, Shaun R.
    Conneally, Eibhlin
    BLOOD, 2007, 110 (11) : 699A - 700A
  • [39] Coexistence of AML1/RUNX1 and BCR-ABL point mutations in an imatinib-resistant form of CML
    Corm, S
    Biggio, V
    Roche-Lestienne, C
    Laï, JL
    Yakoub-Agha, I
    Philippe, N
    Nicolini, FE
    Facon, T
    Preudhomme, C
    LEUKEMIA, 2005, 19 (11) : 1991 - 1992
  • [40] Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate
    Jabbour, E.
    Kantarjian, H.
    Jones, D.
    Talpaz, M.
    Bekele, N.
    O'Brien, S.
    Zhou, X.
    Luthra, R.
    Garcia-Manero, G.
    Giles, F.
    Rios, M. B.
    Verstovsek, S.
    Cortes, J.
    LEUKEMIA, 2006, 20 (10) : 1767 - 1773
12345